The Invokana lawsuit claims the maker of Invokana failed to warn patients and physicians of the increased risks of amputations. As of May 2018, more than 950 lawsuits are filed in federal court against the Invokana manufacturers. Plaintiffs claim that Invokana caused them to suffer amputations, kidney damage, and/or ketoacidosis. Yet, the makers of Invokana failed to warn doctors and patients of these potential side effects.
Invokana is one of a class of drugs known as SGLT2 inhibitors that blocks glucose (sugar) from being absorbed into the bloodstream. Canagliflozin, the active ingredient in Invokana, is the first of four SGLT2 inhibitors approved in the U.S., though other drugs in the class are used elsewhere in the world.
Some Invokana users experienced cardiovascular issues including heart attacks and strokes, as well as diabetic ketoacidosis and kidney health issues. Final results from two clinical studies, CANVAS and CANVAS-R have shown that use of Invokana may double the risk for limb amputation and have prompted the FDA to release a black box warning about the risk.
Side Effects of Invokana
A number of serious adverse events have been linked to Invokana. These severe side effects include:
- Kidney injury and kidney failure
- Urinary tract infection
- Cardiovascular problems including heart attack and stroke
- Diabetic ketoacidosis
- Amputation of the leg, foot or toe
In response to these devastating medical emergencies, many Invokana users have opted to take legal action against the makers of the drug. Both Janssen Pharmaceuticals and its parent company, Johnson & Johnson, allegedly failed to warn consumers and doctors about the risks linked to their drug.
Capitol Legal LLP is currently accepting INVOKANA induced injury cases in all 50 states. If you or somebody you know was injured by taking INVOKANA, you should contact our lawyers immediately for a free case consultation.